Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gennaro D'Amato

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
European Journal of Pharmacology|February 9, 2006
Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseasesGennaro D'Amato
Allergy|July 30, 2002
Environmental urban factors (air pollution and allergens) and the rising trends in allergic respiratory diseasesGennaro D'Amato
Idrugs : the Investigational Drugs Journal|July 5, 2008
World Asthma and COPD Forum. Tackling asthma, COPD and allergic diseasesGennaro D'Amato
Multidisciplinary Respiratory Medicine|September 11, 2012
Effects of climatic changes and urban air pollution on the rising trends of respiratory allergy and asthmaGennaro D'Amato
Idrugs : the Investigational Drugs Journal|July 5, 2008
World Asthma and COPD Forum. Clinical trial results with omalizumabGennaro D'Amato
Expert Opinion on Biological Therapy|March 29, 2003
Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibodyGennaro D'Amato
Drugs in Context|June 4, 2026
Advances in the management of allergic rhinitis: clinical relevance of the mometasone furoate-olopatadine association and the challenge of patient self-diagnosis and self-treatmentMaria D'Amato, Gennaro D'Amato
Current Opinion in Pediatrics|March 14, 2023
Climate change, air pollution, pollen allergy and extreme atmospheric eventsGennaro D'Amato, Maria D'Amato
The Journal of Allergy and Clinical Immunology|January 30, 2007
Drugs may also induce allergic reactions in sensitized individuals through passionate kissingGennaro Liccardi, Gennaro D'Amato
Allergy|August 2, 2020
Global warming, climate change, air pollution and allergiesGennaro D'Amato, Cezmi A Akdis
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
European Journal of Pharmacology|February 9, 2006
Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseasesGennaro D'Amato
Allergy|July 30, 2002
Environmental urban factors (air pollution and allergens) and the rising trends in allergic respiratory diseasesGennaro D'Amato
Idrugs : the Investigational Drugs Journal|July 5, 2008
World Asthma and COPD Forum. Tackling asthma, COPD and allergic diseasesGennaro D'Amato
Multidisciplinary Respiratory Medicine|September 11, 2012
Effects of climatic changes and urban air pollution on the rising trends of respiratory allergy and asthmaGennaro D'Amato
Idrugs : the Investigational Drugs Journal|July 5, 2008
World Asthma and COPD Forum. Clinical trial results with omalizumabGennaro D'Amato
Expert Opinion on Biological Therapy|March 29, 2003
Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibodyGennaro D'Amato
Drugs in Context|June 4, 2026
Advances in the management of allergic rhinitis: clinical relevance of the mometasone furoate-olopatadine association and the challenge of patient self-diagnosis and self-treatmentMaria D'Amato, Gennaro D'Amato
Current Opinion in Pediatrics|March 14, 2023
Climate change, air pollution, pollen allergy and extreme atmospheric eventsGennaro D'Amato, Maria D'Amato
The Journal of Allergy and Clinical Immunology|January 30, 2007
Drugs may also induce allergic reactions in sensitized individuals through passionate kissingGennaro Liccardi, Gennaro D'Amato
Allergy|August 2, 2020
Global warming, climate change, air pollution and allergiesGennaro D'Amato, Cezmi A Akdis
Pageof 12